Rossi, Kimms & McDowell LLP
Delivery system for cytotoxic drugs by bispecific antibody pretargeting
The present invention relates to methods and compositions for pretargeting delivery of therapeutic agents. In preferred embodiments, the pretargeting method comprises: a) administering a bispecific antibody with a first binding site for a disease-associated antigen and a hapten on a targetable construct; b) administering a targetable construct comprising at least one therapeutic agent. In preferred embodiments, the bispecific antibody is made by the dock-and-lock (DNL) technique. In a more preferred embodiment, the targetable construct comprises one or more SN-38 moieties.
Immunomedics, Inc.
C Y A C C C C C C A C A C C C C C A C A C C A C C A C C C A A A C C A
C07K Y02A A61K C07K C07K C07K C07K C07K C07K A61K C07K A61K C07K C07K C07K C07K C07K A61K C07K A61K C07K C07K A61K C07K C07K A61K C07K C07K C07K A61K A61K A61K C07K C07K A61K
inventional additional additional inventional additional inventional inventional inventional inventional inventional additional inventional inventional inventional additional additional inventional inventional inventional inventional inventional additional inventional inventional additional inventional additional additional additional inventional inventional inventional inventional additional inventional
William J. David M. Christopher A. Chien-Hsing
McBride Goldenberg D'Souza Chang